Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2007 Filed Jan 3, 2008 15:45 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 63 | $22.73 | $1,431.99 |
DisclosureSEC source: 0000078003-08-000007 · fec1660.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,660 Underlying: Common Stock · 63 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2007 Filed Jan 3, 2008 15:45 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 122 | $22.73 | $2,773.06 |
DisclosureSEC source: 0000078003-08-000008 · kin1661.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,555 Underlying: Common Stock · 122 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2007 Filed Jan 3, 2008 15:45 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 197 | $22.73 | $4,477.81 |
DisclosureSEC source: 0000078003-08-000009 · rea1662.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,081 Underlying: Common Stock · 197 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2007 Filed Jan 3, 2008 15:45 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 384 | $22.73 | $8,728.32 |
DisclosureSEC source: 0000078003-08-000011 · she1664.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,933 Underlying: Common Stock · 384 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2007 Filed Jan 3, 2008 15:45 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 58 | $22.73 | $1,318.34 |
DisclosureSEC source: 0000078003-08-000010 · ric1663.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,748 Underlying: Common Stock · 58 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2007 Filed Jan 3, 2008 15:45 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 46 | $22.73 | $1,045.58 |
DisclosureSEC source: 0000078003-08-000012 · wax1665.xml · derivative · entry 3 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,988 Underlying: Common Stock · 46 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2007 Filed Jan 3, 2008 15:45 UTC |
WAXMAN ALLEN PSenior Vice President
|
Tax withholdingCommon Stock | 3,659 | $22.73 | $83,169.07 |
DisclosureSEC source: 0000078003-08-000012 · wax1665.xml · nonDerivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,406 Read SEC document |
| December 14, 2007 Filed Dec 18, 2007 16:52 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 42 | $23.10 | $970.20 |
DisclosureSEC source: 0000078003-07-000338 · bag1650.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,901 Underlying: Common Stock · 42 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 14, 2007 Filed Dec 18, 2007 16:52 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 48 | $23.10 | $1,108.80 |
DisclosureSEC source: 0000078003-07-000339 · can1651.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143 Underlying: Common Stock · 48 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 14, 2007 Filed Dec 18, 2007 16:52 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 64 | $23.10 | $1,478.40 |
DisclosureSEC source: 0000078003-07-000340 · fec1652.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,597 Underlying: Common Stock · 64 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 14, 2007 Filed Dec 18, 2007 16:52 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 122 | $23.10 | $2,818.20 |
DisclosureSEC source: 0000078003-07-000341 · kin1653.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,433 Underlying: Common Stock · 122 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 14, 2007 Filed Dec 18, 2007 16:53 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 198 | $23.10 | $4,573.80 |
DisclosureSEC source: 0000078003-07-000342 · rea1654.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,884 Underlying: Common Stock · 198 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 14, 2007 Filed Dec 18, 2007 16:53 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 59 | $23.10 | $1,362.90 |
DisclosureSEC source: 0000078003-07-000343 · ric1655.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,690 Underlying: Common Stock · 59 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 14, 2007 Filed Dec 18, 2007 16:53 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 387 | $23.10 | $8,939.70 |
DisclosureSEC source: 0000078003-07-000344 · she1656.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,549 Underlying: Common Stock · 387 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 14, 2007 Filed Dec 18, 2007 16:53 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 55 | $23.10 | $1,270.50 |
DisclosureSEC source: 0000078003-07-000345 · wax1657.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,942 Underlying: Common Stock · 55 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2007 Filed Dec 4, 2007 13:21 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 40 | $23.76 | $950.40 |
DisclosureSEC source: 0000078003-07-000329 · bag1642.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,859 Underlying: Common Stock · 40 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2007 Filed Dec 4, 2007 13:21 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 47 | $23.76 | $1,116.72 |
DisclosureSEC source: 0000078003-07-000330 · can1643.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95 Underlying: Common Stock · 47 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2007 Filed Dec 4, 2007 13:21 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 54 | $23.76 | $1,283.04 |
DisclosureSEC source: 0000078003-07-000331 · fec1644.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,533 Underlying: Common Stock · 54 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2007 Filed Dec 4, 2007 13:21 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 178 | $23.76 | $4,229.28 |
DisclosureSEC source: 0000078003-07-000333 · rea1646.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,686 Underlying: Common Stock · 178 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2007 Filed Dec 4, 2007 13:21 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 113 | $23.76 | $2,684.88 |
DisclosureSEC source: 0000078003-07-000332 · kin1645.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,311 Underlying: Common Stock · 113 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2007 Filed Dec 4, 2007 13:22 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 49 | $23.76 | $1,164.24 |
DisclosureSEC source: 0000078003-07-000334 · ric1647.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,631 Underlying: Common Stock · 49 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2007 Filed Dec 4, 2007 13:22 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 337 | $23.76 | $8,007.12 |
DisclosureSEC source: 0000078003-07-000335 · she1648.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,162 Underlying: Common Stock · 337 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2007 Filed Dec 4, 2007 13:22 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 52 | $23.76 | $1,235.52 |
DisclosureSEC source: 0000078003-07-000336 · wax1649.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,887 Underlying: Common Stock · 52 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2007 Filed Nov 16, 2007 21:13 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 88 | $23.29 | $2,049.52 |
DisclosureSEC source: 0000078003-07-000321 · bag1634.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,819 Underlying: Common Stock · 88 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2007 Filed Nov 16, 2007 21:13 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 48 | $23.29 | $1,117.92 |
DisclosureSEC source: 0000078003-07-000322 · can1635.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48 Underlying: Common Stock · 48 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2007 Filed Nov 16, 2007 21:13 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 325 | $23.29 | $7,569.25 |
DisclosureSEC source: 0000078003-07-000323 · fec1636.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,479 Underlying: Common Stock · 325 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2007 Filed Nov 16, 2007 21:13 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 355 | $23.29 | $8,267.95 |
DisclosureSEC source: 0000078003-07-000324 · kin1637.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,198 Underlying: Common Stock · 355 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2007 Filed Nov 16, 2007 21:13 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 625 | $23.29 | $14,556.25 |
DisclosureSEC source: 0000078003-07-000325 · rea1638.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,508 Underlying: Common Stock · 625 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2007 Filed Nov 16, 2007 21:14 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 307 | $23.29 | $7,150.03 |
DisclosureSEC source: 0000078003-07-000326 · ric1639.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,582 Underlying: Common Stock · 307 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2007 Filed Nov 16, 2007 21:14 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 1,551 | $23.29 | $36,122.79 |
DisclosureSEC source: 0000078003-07-000327 · she1640.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,825 Underlying: Common Stock · 1,551 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2007 Filed Nov 16, 2007 21:14 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 113 | $23.29 | $2,631.77 |
DisclosureSEC source: 0000078003-07-000328 · wax1641.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,835 Underlying: Common Stock · 113 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 08, 2007 Filed Nov 9, 2007 19:51 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
OtherCommon Stock | 7,878 | $23.11 | $182,060.58 |
DisclosureSEC source: 0000078003-07-000315 · can1633.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Indirect · By Rule 16b-3 Plan Disclosed balance after: 0 Read SEC document |
| November 07, 2007 Filed Nov 8, 2007 20:14 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GiftCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000312 · kin1631.xml · nonDerivative · entry 3 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust for Son Disclosed balance after: 650 F1 · kind: These transactions constitute gifts by the reporting person to trusts for the benefit of each of his children. F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares held by such trust. Read SEC document |
| November 07, 2007 Filed Nov 8, 2007 20:14 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GiftCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000312 · kin1631.xml · nonDerivative · entry 2 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust for Daughter Disclosed balance after: 650 F1 · kind: These transactions constitute gifts by the reporting person to trusts for the benefit of each of his children. F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares held by such trust. Read SEC document |
| November 07, 2007 Filed Nov 8, 2007 20:14 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GiftCommon Stock | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000312 · kin1631.xml · nonDerivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,013 F1 · kind: These transactions constitute gifts by the reporting person to trusts for the benefit of each of his children. Read SEC document |
| November 07, 2007 Filed Nov 8, 2007 20:14 UTC |
READ IAN CSenior Vice President
|
SaleCommon Stock | 1,885 | $23.50 | $44,297.50 |
DisclosureSEC source: 0000078003-07-000313 · rea1630.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,096 Read SEC document |
| November 07, 2007 Filed Nov 8, 2007 20:14 UTC |
READ IAN CSenior Vice President
|
SaleCommon Stock | 18,115 | $23.48 | $425,340.20 |
DisclosureSEC source: 0000078003-07-000313 · rea1630.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,981 Read SEC document |
| November 06, 2007 Filed Nov 8, 2007 21:41 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
OtherPhantom Stock Units SSP · Derivative | 7,387 | $23.93 | $176,770.91 |
DisclosureSEC source: 0000078003-07-000314 · can1632.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,387 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 31, 2007 Filed Nov 1, 2007 20:53 UTC |
GOODMAN COREY SSenior Vice President
|
GrantEmployee Stock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $24.61 | $0.00 |
DisclosureSEC source: 0000078003-07-000296 · goo1620.xml · derivative · entry 2 GOODMAN COREY S · CIK 0001278411 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2017-10-30 Read SEC document |
| October 31, 2007 Filed Nov 1, 2007 20:53 UTC |
GOODMAN COREY SSenior Vice President
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000296 · goo1620.xml · nonDerivative · entry 1 GOODMAN COREY S · CIK 0001278411 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| October 31, 2007 Filed Nov 1, 2007 20:53 UTC |
MACKAY MARTINSenior Vice President
|
GrantEmployee Stock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $24.61 | $0.00 |
DisclosureSEC source: 0000078003-07-000297 · mac1621.xml · derivative · entry 3 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2017-10-30 Read SEC document |
| October 31, 2007 Filed Nov 1, 2007 20:53 UTC |
MACKAY MARTINSenior Vice President
|
GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000297 · mac1621.xml · nonDerivative · entry 1 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,255 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| October 31, 2007 Filed Nov 1, 2007 21:16 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 39 | $24.61 | $959.79 |
DisclosureSEC source: 0000078003-07-000298 · bag1622.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,731 Underlying: Common Stock · 39 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 31, 2007 Filed Nov 1, 2007 21:16 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 45 | $24.61 | $1,107.45 |
DisclosureSEC source: 0000078003-07-000299 · can1623.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,386 Underlying: Common Stock · 45 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 31, 2007 Filed Nov 1, 2007 21:16 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 58 | $24.61 | $1,427.38 |
DisclosureSEC source: 0000078003-07-000300 · fec1624.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,154 Underlying: Common Stock · 58 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 31, 2007 Filed Nov 1, 2007 21:16 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 113 | $24.61 | $2,780.93 |
DisclosureSEC source: 0000078003-07-000301 · kin1625.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,843 Underlying: Common Stock · 113 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 31, 2007 Filed Nov 1, 2007 21:16 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 181 | $24.61 | $4,454.41 |
DisclosureSEC source: 0000078003-07-000302 · rea1626.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,883 Underlying: Common Stock · 181 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 31, 2007 Filed Nov 1, 2007 21:17 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 53 | $24.61 | $1,304.33 |
DisclosureSEC source: 0000078003-07-000303 · ric1627.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,275 Underlying: Common Stock · 53 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 31, 2007 Filed Nov 1, 2007 21:17 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 352 | $24.61 | $8,662.72 |
DisclosureSEC source: 0000078003-07-000304 · she1628.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,274 Underlying: Common Stock · 352 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 31, 2007 Filed Nov 1, 2007 21:17 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 51 | $24.61 | $1,255.11 |
DisclosureSEC source: 0000078003-07-000305 · wax1629.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,722 Underlying: Common Stock · 51 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.